Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable value (Q83462160)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 February 2011
edit
Language Label Description Also known as
English
Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable value
scientific article published on 22 February 2011

    Statements

    Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable value (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit